C509-0197 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide

C509-0197 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide
C509-0197 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C509-0197
N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C509-0197

Molecular Formula

C25H25ClN4OS (C25 H25 ClN4 OS)

Compound Name

N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-3-(4-chlorophenyl)-1-methyl-1H-thieno[23-c]pyrazole-5-carboxamide

SMILES

Cn(c1c2cc(C(NC3CCN(Cc4ccccc4)CC3)=O)s1)nc2-c(cc1)ccc1Cl

InChI

InChI=1S/C25H25ClN4OS/c1-29-25-21(23(28-29)18-7-9-19(26)10-8-18)15-22(32-25)24(31)27-20-11-13-30(14-12-20)16-17-5-3-2-4-6-17/h2-10,15,20H,11-14,16H2,1H3,(H,27,31)

InChI Key

IUYGIGUQHBOKIN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14763003

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.02

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.779

Distribution Coefficient, logD

3.334

Water Solubility, LogSw

-4.88

Polar Surface Area

43.035

Acid Dissociation Constant (pKa)

16.28

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

C509-0197 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with C509-0197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C509-0197?
Check Price and Availability of C509-0197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C509-0197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C509-0197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C509-0197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C509-0197 available by request